1-20 of 28
Boglarka Gyurkocza, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Clinical Outcomes of Acute Myeloid Leukemia Patients Bridged to Allogeneic Stem Cell Transplant By Venetoclax Combination Therapy

Maximilian Stahl, MD, Kamal Menghrajani, MD, Andriy Derkach, PhD, Susan DeWolf, MD, Josel D Ruiz, MPH, Doris M Ponce, MD, Brian C. Shaffer, MD, Roni Tamari, MD, James W. Young, MD, Juliet Barker, MBBS, Ann A. Jakubowski, MDPhD, Boglarka Gyurkocza, MD, Alexander Chan, Wenbin Xiao, MD PhD, Jacob L Glass, MDPhD, Amber C. King, PharmD, BCOP, Sheng F Cai, MDPhD, Anthony Daniyan, MD, Christopher Famulare, MS, Bernadette M. Cuello, BSN, MSN, NP, RN, Troy Z. Horvat, PharmD, BCOP, Eytan M. Stein, MD, Mikhail Roshal, MD PhD, Sergio Giralt, MD, Miguel-Angel Perales, MD, Christina Cho, MD, Martin S. Tallman, MD, Aaron D Goldberg, MDPhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 16–17.
https://doi.org/10.1182/blood-2020-137749
Published: 2020
Journal Articles

High Doses of Targeted Radiation with Anti-CD45 Iodine ( 131 I) Apamistamab [Iomab-B] Do Not Correlate with Incidence of Mucositis, Febrile Neutropenia or Sepsis in the Prospective, Randomized Phase 3 Sierra Trial for Patients with Relapsed or Refractory Acute Myeloid Leukemia

Boglarka Gyurkocza, MD, Rajneesh Nath, MD, Hannah Choe, MD, Stuart Seropian, MD, Patrick J. Stiff, MD, Sunil Abhyankar, MD, Edward Agura, MD, Mark Litzow, MD, Benjamin K. Tomlinson, MD, George L. Chen, MD, Parameswaran Hari, MD MRCP, Johnnie Orozco, MD, Zaid S. Al-Kadhimi, MD, Camille Abboud, MD, Koen Van Besien, MD PhD, Mitchell Sabloff, MSc,MDFRCPC, Margarida Magalhaes Magalhaes-Silverman, James M. Foran, MD, Michael W. Schuster, MD, Partow Kebriaei, MD, Moshe Levy, MD, Hillard M Lazarus, MD, Sergio A. Giralt, MD, Qing Liang, PhD, Mark S. Berger, MD, Vijay Reddy, MDPhD, John M. Pagel, MDPhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 30–31.
https://doi.org/10.1182/blood-2020-134624
Published: 2020
Journal Articles

Molecular Predictors and Effectiveness of Measurable Residual Disease (MRD) Eradication with Chemotherapy and Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia

Maximilian Stahl, MD, Andriy Derkach, PhD, Christopher Famulare, MS, Christina Cho, MD, Sean Devlin, PhD, Noushin Farnoud, PhD, Kamal Menghrajani, MD, Minal A Patel, MPH, Sheng F Cai, MDPhD, Mark B. Geyer, MD, Andrew Dunbar, MD, Zachary D. Epstein-Peterson, MD, Erin McGovern, BA, Jessica Schulman, BSc, Jacob L Glass, MDPhD, Justin Taylor, MD, Aaron D Viny, MDMS, Eytan M. Stein, MD, Bartlomiej Getta, FRCPA, FRACP, MBBS, Maria E. Arcila, MD, Ross L. Levine, MD, Juliet Barker, MBBS, Brian C. Shaffer, MD, Esperanza B. Papadopoulos, MD, Boglarka Gyurkocza, MD, Miguel-Angel Perales, MD, Omar Abdel-Wahab, MD, Elli Papaemmanuil, PhD, Sergio A. Giralt, MD, Yanming Zhang, MD, Mikhail Roshal, MD PhD, Martin S. Tallman, MD, Aaron D Goldberg, MDPhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 18–20.
https://doi.org/10.1182/blood-2020-137552
Published: 2020
Journal Articles

Personalized Targeted Radioimmunotherapy with Anti-CD45 Iodine ( 131 I) Apamistamab [Iomab-B] in Patients with Active Relapsed or Refractory Acute Myeloid Leukemia Results in Successful Donor Hematopoietic Cells Engraftment with the Timing of Engraftment Not Related to the Radiation Dose Delivered

Boglarka Gyurkocza, MD, Rajneesh Nath, MD, Hannah Choe, MD, Stuart Seropian, MD, Patrick J. Stiff, MD, Sunil Abhyankar, MD, Edward Agura, MD, Mark Litzow, MD, Benjamin K. Tomlinson, MD, George L. Chen, MD, Parameswaran Hari, MD MRCP, Johnnie Orozco, MD, Zaid S. Al-Kadhimi, MD, Camille Abboud, MD, Koen Van Besien, MD PhD, Mitchell Sabloff, MSc,MDFRCPC, Margarida Magalhaes Magalhaes-Silverman, James M. Foran, MD, Michael W. Schuster, MD, Partow Kebriaei, MD, Moshe Y. Levy, MD, Hillard M Lazarus, MD, Sergio A. Giralt, MD, Qing Liang, PhD, Mark S. Berger, MD, Vijay Reddy, MDPhD, John M. Pagel, MDPhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 42–44.
https://doi.org/10.1182/blood-2020-134948
Published: 2020
Journal Articles

Re-Induction and Targeted Conditioning with Anti-CD45 Iodine ( 131 I) Apamistamab [Iomab-B] Leads to High Rates of Transplantation and Successful Engraftment in Older Patients with Active, Relapsed or Refractory (rel/ref) AML after Failure of Chemotherapy and Targeted Agents: Preliminary Midpoint Results from the Prospective, Randomized Phase 3 Sierra Trial

Boglarka Gyurkocza, MD, Rajneesh Nath, MD, Patrick J. Stiff, MD, Edward Agura, MD, Mark Litzow, MD, Ben Tomlinson, MD, Hannah K. Choe, MD, Sunil Abhyankar, MD, Stuart Seropian, MD, George L. Chen, MD, Parameswaran Hari, MBBS, MD, Zaid S. Al-Kadhimi, MD, James M. Foran, MD, Johnnie Orozco, MD, Koen Van Besien, MD PhD, Mitchell Sabloff, MD, Partow Kebriaei, MD, Moshe Yair Levy, MD, Hillard M Lazarus, MD, Sergio A Giralt, MD, Mark S. Berger, MD, Vijay Reddy, MD PhD, John M. Pagel, MD PhD DSc
Journal: Blood
Blood (2019) 134 (Supplement_1): 5642.
https://doi.org/10.1182/blood-2019-122776
Published: 2019
Journal Articles

Feasibility of Administering Anti-CD45 Iodine ( 131 I) Apamistamab [Iomab-B] for Re-Induction and Targeted Conditioning in Older Patients with Active, Relapsed or Refractory AML without Lead-Lined Rooms: Sierra Trial Experience at MSKCC

Bae P Chu, MPH, Neeta Pandit-Taskar, MD, Boglarka Gyurkocza, MD, Qing Liang, PhD, Daniel Miodownik, MPH, Vijay Reddy, MD PhD, Mark S. Berger, MD, Lawrence T. Dauer, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5839.
https://doi.org/10.1182/blood-2019-131230
Published: 2019
Journal Articles

Sierra Clinical Trial Dosimetry Results Support Low Dose Anti-CD45 Iodine (131I) Apamistamab [Iomab-B] for Targeted Lymphodepletion Prior to Adoptive Cell Therapy

Rajneesh Nath, MD, Eileen M Geoghegan, Matthew L. Ulrickson, MD, Jennifer A Spross, MA, Renee H Lichtenstein, BA, Sandy Konerth, MS, Darrell R. Fisher, PhD, Qing Liang, PhD, Dale Ludwig, PhD BS, Vijay Reddy, MD PhD, Mark S. Berger, MD, Boglarka Gyurkocza, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1958.
https://doi.org/10.1182/blood-2019-128838
Published: 2019
Journal Articles

Pre-Transplant Fecal Microbial Diversity Independently Predicts Critical Illness after Hematopoietic Cell Transplantation

Fatima I. Adhi, MD, Eric R. Littmann, BA, Ying Taur, MD MPH, Molly A. Maloy, MS, Kate A Markey, PhDMBBS,FRACP, Emily Fontana, BA, Luigi A Amoretti, B.S., Roberta Wright, M.S., M.B.S., Miriam Sanchez-Escamilla, MD, Nerea Castillo Flores, MD PhD, Ana Alarcon Tomas, MD, Richard J Lin, MD PhD, Lucrecia Yáñez, MD PhD, Daniel Brereton, B.A., Annelie Clurman, BA, John B. Slingerland, BSc, Gunjan L. Shah, MD, Christina Cho, MD, Michael Scordo, MD, Ioannis Politikos, MD, Boglarka Gyurkocza, MD, Doris M Ponce, MD, Juliet Barker, MBBS, Miguel-Angel Perales, MD, Sergio A Giralt, MD, Marcel R.M. van den Brink, MD PhD, Eric G. Pamer, MD, Jonathan U. Peled, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3264.
https://doi.org/10.1182/blood-2019-124902
Published: 2019
Journal Articles

Loss of Microbiota Diversity after Autologous Stem Cell Transplant Is Comparable to Injury in Allogeneic Stem Cell Transplant

Niloufer Khan, MD, Jonathan U. Peled, MD PhD, Antonio LC Gomes, PhD, Sean M Devlin, PhD, Carlos Rondon-Clavo, MD, Annelie Clurman, BA, John B. Slingerland, BSc, Ann E. Slingerland, BSc, Molly Maloy, MS, Anthony D. Sung, MD, Nelson J. Chao, MD, Craig S. Sauter, MD, Heather J. Landau, MD, Doris Ponce, MD, Boglarka Gyurkocza, MD, Gunjan L. Shah, MD, Michael Scordo, MD, Parastoo B. Dahi, MD, Miguel-Angel Perales, MD, Robert R. Jenq, MD, Sergio Giralt, MD, Eric G. Pamer, MD, Marcel R.M. van den Brink, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 608.
https://doi.org/10.1182/blood-2018-99-110857
Published: 2018
Journal Articles

Multicenter Microbiota Analysis Indicates That Pre-HCT Microbiota Injury Is Prevalent across Geography and Predicts Poor Overall Survival

Jonathan U. Peled, MD PhD, Antonio LC Gomes, PhD, Christoph K. Stein-Thoeringer, MD, John B. Slingerland, BSc, Ann E. Slingerland, BSc, Daniela Weber, MSc, Kate A Markey, PhDMBBS, Melody Smith, MD, Doris Ponce, MD, Annelie Clurman, BA, Anthony D. Sung, MD, Daigo Hashimoto, MD, PhD, Molly Maloy, MS, Niloufer Khan, MD, Boglarka Gyurkocza, MD, Sergio Giralt, MD, Miguel-Angel Perales, MD, Robert R. Jenq, MD, Ying Taur, MD MPH, Xavier B. Joao, PhD, Eric G. Pamer, MD, Takanori Teshima, Nelson J. Chao, MD, Ernst Holler, MD, Marcel R.M. van den Brink, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 811.
https://doi.org/10.1182/blood-2018-99-116967
Published: 2018
Journal Articles

A High Degree of Engrafting Unit-Recipient HLA-Allele Mismatch Is Not Associated with an Increased Risk of Transplant-Related Mortality (TRM) or Inferior Progression-Free Survival (PFS) after Double Unit Cord Blood (CB) Transplantation (dCBT) in Adults with Hematologic Malignancies

Ioannis Politikos, MD, Sean M Devlin, PhD, Molly Maloy, MS, Christopher Mazis, BS, Kristine Naputo, BA, Aishat Olaide Afuye, BA, Andromachi Scaradavou, MD, Scott T Avecilla, MD PhD, Hugo R. Castro-Malaspina, MD, Christina Cho, MD, Parastoo B. Dahi, MD, Sergio Giralt, MD, Boglarka Gyurkocza, MD, Ann A. Jakubowski, MDPhD, Esperanza B. Papadopoulos, MD, Miguel-Angel Perales, MD, Craig S. Sauter, MD, Michael Scordo, MD, Brian C. Shaffer, MD, Gunjan L. Shah, MD, Roni Tamari, MD, Marcel R.M. van den Brink, MD PhD, James W. Young, MD, Doris Ponce, MD, Juliet Barker, MBBS
Journal: Blood
Blood (2018) 132 (Supplement 1): 3470.
https://doi.org/10.1182/blood-2018-99-116477
Published: 2018
Journal Articles

Molecular Predictors and Current Management of Minimal Residual Disease (MRD) Following Induction Chemotherapy for Acute Myeloid Leukemia (AML)

Aaron D Goldberg, MDPhD, Christopher Famulare, MS, Sean M Devlin, PhD, Noushin Farnoud, PhD, Kamal Menghrajani, MD, Minal Patel, BA, Sheng Cai, MD PhD, Andrew Dunbar, MD, Zachary D. Epstein-Peterson, MD, Erin McGovern, BA, Jessica Schulman, Jacob L Glass, MDPhD, Justin Taylor, MD, Aaron D Viny, MDMS, Bartlomiej Getta, FRCPA, FRACP, MBBS, Maria E Arcila, MD, Ross L. Levine, MD, Brian C. Shaffer, MD, Boglarka Gyurkocza, MD, Esperanza B. Papadopoulos, MD, Miguel-Angel Perales, MD, Elli Papaemmanuil, PhD, Sergio Giralt, MD, Yanming Zhang, MD, Mikhail Roshal, MD PhD, Martin S. Tallman, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 292.
https://doi.org/10.1182/blood-2018-99-112938
Published: 2018
Journal Articles

Targeted Conditioning of Iomab-B ( 131 I-anti-CD45) Prior to Allogeneic Hematopoietic Cell Transplantation Versus Conventional Care in Relapsed or Refractory Acute Myeloid Leukemia (AML): Preliminary Feasibility and Safety Results from the Prospective, Randomized Phase 3 Sierra Trial

Edward Agura, MD, Boglarka Gyurkocza, MD, Rajneesh Nath, MD, Mark R. Litzow, MD, Benjamin K. Tomlinson, MD, Sunil Abhyankar, MD, Stuart Seropian, MD, Patrick J. Stiff, MD, Hannah K. Choe, MD, Partow Kebriaei, MD, James M. Foran, MD, George Chen, MD, Moshe Yair Levy, MD, Hillard M Lazarus, MD, Sergio Giralt, MD, Mark S. Berger, MD, Vijay Reddy, MD PhD, John M. Pagel, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1017.
https://doi.org/10.1182/blood-2018-99-111914
Published: 2018
Journal Articles

Double-Unit Cord Blood (CB) Transplantation with Haplo-Identical CD34+ Cells (haplo-dCBT) May Speed Neutrophil Recovery Although Successful Bridging Is Contingent on Close Haplo-Winning CB Unit HLA-Match

Ioannis Politikos, MD, Sean M Devlin, PhD, Christopher Mazis, BS, Molly Maloy, MS, Kristine Naputo, BA, Aishat Olaide Afuye, BA, Valkal Bhatt, PharmD, BCOP, BCPS, Andromachi Scaradavou, MD, Richard J. O'Reilly, MD, Scott T Avecilla, MD PhD, Hugo R. Castro-Malaspina, MD, Christina Cho, MD, Parastoo B. Dahi, MD, Sergio Giralt, MD, Boglarka Gyurkocza, MD, Katharine C. Hsu, MD PhD, Ann A. Jakubowski, MD PhD, Esperanza B. Papadopoulos, MD, Miguel-Angel Perales, MD, Craig S. Sauter, MD, Michael Scordo, MD, Brian C. Shaffer, MD, Gunjan L. Shah, MD, Roni Tamari, MD, Marcel R.M. van den Brink, MD PhD, James W. Young, MD, Doris Ponce, MD, Juliet Barker, MBBS
Journal: Blood
Blood (2018) 132 (Supplement 1): 2078.
https://doi.org/10.1182/blood-2018-99-116276
Published: 2018
Journal Articles

Impact of Omitting Post-Transplant Mini-Methotrexate Doses in Allogeneic Hematopoietic Cell Transplantation: A Single-Center Retrospective Study

Andrew Lin, PharmD, Patrick Hilden, MS, Molly Maloy, MS, Ann A. Jakubowski, MD PhD, Esperanza B. Papadopoulos, MD, Craig S. Sauter, MD, Roni Tamari, MD, Doris Ponce, MD, Sergio A. Giralt, MD, Boglarka Gyurkocza, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3255.
https://doi.org/10.1182/blood.V130.Suppl_1.3255.3255
Published: 2017
Journal Articles

Long-Term Follow-up of Adult Double Unit Cord Blood (CB) Transplantation (dCBT) Recipients Reveals High Rates of Progression-Free Survival after a Novel Cy/ Flu/ Thio/ TBI 400 Intermediate Intensity Conditioning Regimen

Ioannis Politikos, MD, Sean M. Devlin, PhD, Alexandra Jacob, Molly Maloy, MS, Christopher Mazis, Kristine Naputo, Andromachi Scaradavou, MD, Richard O'Reilly, MD, Scott Avecilla, MD PhD, H.R. Castro-Malaspina, MD, Parastoo B. Dahi, MD, Sergio A. Giralt, MD, Boglarka Gyurkocza, MD, Ann A. Jakubowski, MD PhD, Esperanza B. Papadopoulos, MD, Jonathan U. Peled, MD PhD, Miguel-Angel Perales, MD, Craig S. Sauter, MD, Brian C. Shaffer, MD, Gunjan L. Shah, MD, Roni Tamari, MD, Marcel R.M. van den Brink, MD PhD, James W. Young, MD, Doris Ponce, MD, Juliet Barker, MBBS
Journal: Blood
Blood (2017) 130 (Supplement 1): 4589.
https://doi.org/10.1182/blood.V130.Suppl_1.4589.4589
Published: 2017
Journal Articles

Adoptive T-Cell Therapy with 3 rd Party CMV-pp65-Specific CTLs for CMV Viremia and Disease Arising after Allogeneic Hematopoietic Stem Cell Transplant

Susan Prockop, MD, Ekaterina Doubrovina, MD PhD, Irene Rodriguez-Sanchez, Aisha N. Hasan, MD, Juliet Barker, MBBS, H.R. Castro-Malaspina, MD, Parastoo B. Dahi, MD, Sergio A. Giralt, MD, Boglarka Gyurkocza, MD, Nancy A. Kernan, MD, Guenther Koehne, MDPhD, Esperanza B. Papadopoulos, MD, Doris Ponce, MD, Craig S. Sauter, MD, Virginia Escobedo, RN, Victoria Szenes, PNP, Karim Baroudy, BS, Alison Slocum, MA, Richard J. O'Reilly, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 747.
https://doi.org/10.1182/blood.V130.Suppl_1.747.747
Published: 2017
Journal Articles

Comparable Survival and Incidence of Toxicity for Older Adult Patients after CD34+ Selected Allogeneic Hematopoietic Stem Cell Transplantation

Gunjan L. Shah, MDMS, Michael Scordo, MD, Satyajit Kosuri, MD, Diego Adrianzen Herrera, MD, Molly A. Maloy, MS, Jimmy Nieves, RN, Sean Devlin, PhD, Taylor Borrill, CCRP, Scott T. Avecilla, MD PhD, Richard C. Meagher, PhD, Richard J. O'Reilly, MD, Guenther Koehne, MD PhD, Brian C. Shaffer, MD, Miguel-Angel Perales, MD, Boglarka Gyurkocza, MD, Hugo R. Castro-Malaspina, MD, Sergio A. Giralt, MD, Roni Tamari, MD
Journal: Blood
Blood (2016) 128 (22): 1236.
https://doi.org/10.1182/blood.V128.22.1236.1236
Published: 2016
Journal Articles

An Analysis of Early Toxicities, Associated Risk Factors and Survival during the First Year in Adults Undergoing Ex-Vivo CD34+ Selected Allogeneic Hematopoietic Cell Transplantation for Hematologic Malignancies

Satyajit Kosuri, MD, Diego Adrianzen Herrera, MD, Michael Scordo, MD, Gunjan Shah, MD M.S., Molly A. Maloy, MS, Sean Devlin, PhD, Jimmy Nieves, RN, Taylor Borrill, CCRP, Scott T. Avecilla, MD PhD, Richard C. Meagher, PhD, Richard J. O'Reilly, MD, Guenther Koehne, MD PhD, Brian C. Shaffer, MD, Boglarka Gyurkocza, MD, Hugo R. Castro-Malaspina, MD, Roni Tamari, MD, Sergio A. Giralt, MD, Miguel Perales, MD
Journal: Blood
Blood (2016) 128 (22): 2194.
https://doi.org/10.1182/blood.V128.22.2194.2194
Published: 2016
Journal Articles

A Comprehensive Analysis of Late Toxicities and Associated Risk Factors in Long-Term Survivors of Myeloablative Conditioned Allogeneic Hematopoietic Cell Transplantation Using Ex-Vivo CD34+ Selection-Based Graft-Versus-Host Disease Prophylaxis

Michael Scordo, MD, Gunjan L. Shah, MDMS, Satyajit Kosuri, MD, Diego Adrianzen Herrera, MD, Sean Devlin, PhD, Molly A. Maloy, MS, Jimmy Nieves, RN, Taylor Borrill, CCRP, Scott T. Avecilla, MD PhD, Richard C. Meagher, PhD, Richard J. O'Reilly, MD, Guenther Koehne, MD PhD, Boglarka Gyurkocza, MD, Hugo Castro-Malaspina, MD, Roni Tamari, MD, Miguel Perales, MD, Sergio A. Giralt, MD, Brian C. Shaffer, MD
Journal: Blood
Blood (2016) 128 (22): 4621.
https://doi.org/10.1182/blood.V128.22.4621.4621
Published: 2016